Shire is reportedly looking at buying U.S.-based NPS Pharmaceuticals.
Shire is reportedly looking at buying U.S.-based NPS Pharmaceuticals.
The news comes just a couple of months after AbbVie dropped its takeover offer for Shire.
Shire received a US$1.64-billion breakup fee after that deal collapsed.
NPS Pharmaceuticals’ current therapeutic areas of focus are gastrointestinal disease and endocrine disorders.
For the full story, visit the Bloomberg News website.
Read:
Meet Elise Dallain, Vice President of Growth and Strategic Relations for TELUS Health Retirement and Benefits Solutions. In her role, Elise oversees pension and administration...
Toronto-based software company Symbility Solutions Inc. has sold its health division to Telus Health for approximately $16.5 million. “We are proud to announce the sale...
Telus Health is acquiring digital health platform Sprout Wellness Solutions. Sprout is designed to inspire employees to improve their health through behaviour change, according to...
Mawer Investment Management Ltd. is pleased to announce the addition of Sylvie Methot and Joel Uncles to the Institutional Client Management team.
Roughly 200 employees of the Ontario Native Women’s Association are joining the Colleges of Applied Arts and Technology’s DBplus pension plan. The ONWA is a...
In 2023, the world’s 300 largest pension funds’ assets under management increased by 10 per cent to US$22.6 trillion, compared to $20.6 trillion at the...
Nearly two-fifths (38 per cent) of benefits plan members are experiencing a general sense of loneliness, isolation and social disconnection, according to the 2024 Benefits...